James Rodberg's most recent trade in Sight Sciences Inc was a trade of 86,940 Common Stock done . Disclosure was reported to the exchange on Feb. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | James Rodberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 86,940 | 238,170 | - | 0 | Common Stock | |
| Sight Sciences Inc | James Rodberg | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 16 Jan 2026 | 2,616 | 151,230 | - | 6.6 | 17,318 | Common Stock |
| Sight Sciences Inc | James Rodberg | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 05 Jan 2026 | 4,405 | 154,440 | - | 7.8 | 34,447 | Common Stock |
| Sight Sciences Inc | James Rodberg | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 05 Jan 2026 | 594 | 153,846 | - | 7.5 | 4,443 | Common Stock |
| Sight Sciences Inc | James Rodberg | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 02 Dec 2025 | 2,518 | 158,845 | - | 8.3 | 20,774 | Common Stock |
| Sight Sciences Inc | James Rodberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2025 | 15,337 | 161,363 | - | 0 | Common Stock | |
| Sight Sciences Inc | James Rodberg | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 20,600 | 699 | - | 0 | Common Stock | |
| Sight Sciences Inc | James Rodberg | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 14,400 | 14,400 | - | - | Stock Option (Right to Buy) |